vs
DBV Technologies S.A.（DBVT）与维珍银河（SPCE）财务数据对比。点击上方公司名可切换其他公司
维珍银河的季度营收约是DBV Technologies S.A.的1.5倍（$4.2M vs $2.8M），DBV Technologies S.A.净利率更高（-1195.5% vs -2222.2%，领先1026.6%），DBV Technologies S.A.同比增速更快（158.8% vs 125.5%），DBV Technologies S.A.自由现金流更多（$-32.6M vs $-113.5M）
DBV Technologies是一家总部位于法国巴涅的公开上市生物制药企业，核心研发成果为Viaskin给药技术，可在不进入血液循环的前提下，让过敏原或抗原作用于完整皮肤。其花生过敏疗法Viaskin Peanut的临床开发，已获得美国食品药品监督管理局授予快速通道资格。
维珍银河控股是英美合资的太空飞行公司，由理查德·布兰森创立，维珍集团通过维珍投资有限公司持有该公司11.9%的股份，公司核心业务围绕商业载人太空旅行展开，是全球商业太空探索领域的先行者。
DBVT vs SPCE — 直观对比
营收规模更大
SPCE
是对方的1.5倍
$2.8M
营收增速更快
DBVT
高出33.2%
125.5%
净利率更高
DBVT
高出1026.6%
-2222.2%
自由现金流更多
DBVT
多$81.0M
$-113.5M
损益表 — Q3 FY2025 vs Q2 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $2.8M | $4.2M |
| 净利润 | $-33.2M | $-93.8M |
| 毛利率 | — | -546.6% |
| 营业利润率 | -1235.7% | -2412.1% |
| 净利率 | -1195.5% | -2222.2% |
| 营收同比 | 158.8% | 125.5% |
| 净利润同比 | -8.9% | 30.2% |
| 每股收益（稀释后） | $-0.24 | $-4.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DBVTSPCE
| Q3 25 | $2.8M | — | ||
| Q2 25 | $1.5M | — | ||
| Q2 24 | $1.2M | $4.2M | ||
| Q1 24 | $1.4M | $2.0M | ||
| Q4 23 | $8.9M | $2.8M | ||
| Q3 23 | $2.4M | $1.7M | ||
| Q2 23 | $2.3M | $1.9M | ||
| Q1 23 | $2.2M | — |
净利润DBVTSPCE
| Q3 25 | $-33.2M | — | ||
| Q2 25 | $-41.9M | — | ||
| Q2 24 | $-33.1M | $-93.8M | ||
| Q1 24 | $-27.3M | $-102.0M | ||
| Q4 23 | $134.3M | $-104.0M | ||
| Q3 23 | $-16.7M | $-104.6M | ||
| Q2 23 | $-24.2M | $-134.4M | ||
| Q1 23 | $-20.6M | — |
毛利率DBVTSPCE
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | -546.6% | ||
| Q1 24 | — | -1038.1% | ||
| Q4 23 | — | -766.4% | ||
| Q3 23 | — | -1384.3% | ||
| Q2 23 | — | 87.5% | ||
| Q1 23 | — | — |
营业利润率DBVTSPCE
| Q3 25 | -1235.7% | — | ||
| Q2 25 | -2806.2% | — | ||
| Q2 24 | -2914.9% | -2412.1% | ||
| Q1 24 | -2029.7% | -5599.9% | ||
| Q4 23 | -134.3% | -4067.8% | ||
| Q3 23 | -770.2% | -6613.0% | ||
| Q2 23 | -1096.0% | -7459.4% | ||
| Q1 23 | -964.7% | — |
净利率DBVTSPCE
| Q3 25 | -1195.5% | — | ||
| Q2 25 | -2858.4% | — | ||
| Q2 24 | -2852.4% | -2222.2% | ||
| Q1 24 | -1943.5% | -5139.1% | ||
| Q4 23 | 1512.8% | -3701.8% | ||
| Q3 23 | -705.6% | -6053.5% | ||
| Q2 23 | -1059.6% | -7181.4% | ||
| Q1 23 | -937.1% | — |
每股收益（稀释后）DBVTSPCE
| Q3 25 | $-0.24 | — | ||
| Q2 25 | $-0.31 | — | ||
| Q2 24 | $-0.34 | $-4.36 | ||
| Q1 24 | $-0.28 | $-5.10 | ||
| Q4 23 | $-0.11 | $-14.49 | ||
| Q3 23 | $-0.17 | $-5.57 | ||
| Q2 23 | $-0.26 | $-9.16 | ||
| Q1 23 | $-0.22 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.8M | $775.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $52.9M | $394.8M |
| 总资产 | $110.5M | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DBVTSPCE
| Q3 25 | $69.8M | — | ||
| Q2 25 | $103.2M | — | ||
| Q2 24 | $66.2M | $775.7M | ||
| Q1 24 | $101.5M | $765.2M | ||
| Q4 23 | $141.4M | $874.0M | ||
| Q3 23 | $149.1M | $997.1M | ||
| Q2 23 | $174.0M | $940.2M | ||
| Q1 23 | $192.3M | — |
股东权益DBVTSPCE
| Q3 25 | $52.9M | — | ||
| Q2 25 | $86.2M | — | ||
| Q2 24 | $79.1M | $394.8M | ||
| Q1 24 | $111.7M | $417.6M | ||
| Q4 23 | $140.2M | $505.5M | ||
| Q3 23 | $144.0M | $599.4M | ||
| Q2 23 | $164.2M | $484.5M | ||
| Q1 23 | $179.1M | — |
总资产DBVTSPCE
| Q3 25 | $110.5M | — | ||
| Q2 25 | $143.4M | — | ||
| Q2 24 | $114.2M | $1.1B | ||
| Q1 24 | $145.9M | $1.1B | ||
| Q4 23 | $183.0M | $1.2B | ||
| Q3 23 | $189.8M | $1.3B | ||
| Q2 23 | $217.5M | $1.1B | ||
| Q1 23 | $232.9M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-32.4M | $-79.1M |
| 自由现金流经营现金流 - 资本支出 | $-32.6M | $-113.5M |
| 自由现金流率自由现金流/营收 | -1173.5% | -2690.7% |
| 资本支出强度资本支出/营收 | 4.2% | 815.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-138.3M | $-458.3M |
8季度趋势，按日历期对齐
经营现金流DBVTSPCE
| Q3 25 | $-32.4M | — | ||
| Q2 25 | $-33.9M | — | ||
| Q2 24 | $-35.1M | $-79.1M | ||
| Q1 24 | $-34.7M | $-113.2M | ||
| Q4 23 | $-13.7M | $-95.3M | ||
| Q3 23 | $-19.6M | $-91.5M | ||
| Q2 23 | $-25.6M | $-125.3M | ||
| Q1 23 | $-20.8M | — |
自由现金流DBVTSPCE
| Q3 25 | $-32.6M | — | ||
| Q2 25 | $-33.9M | — | ||
| Q2 24 | $-35.8M | $-113.5M | ||
| Q1 24 | $-36.0M | $-126.3M | ||
| Q4 23 | $-14.0M | $-113.7M | ||
| Q3 23 | $-19.6M | $-104.8M | ||
| Q2 23 | $-25.7M | $-135.2M | ||
| Q1 23 | $-21.0M | — |
自由现金流率DBVTSPCE
| Q3 25 | -1173.5% | — | ||
| Q2 25 | -2316.5% | — | ||
| Q2 24 | -3084.0% | -2690.7% | ||
| Q1 24 | -2560.6% | -6362.8% | ||
| Q4 23 | -158.2% | -4046.9% | ||
| Q3 23 | -827.3% | -6066.1% | ||
| Q2 23 | -1124.0% | -7224.3% | ||
| Q1 23 | -955.0% | — |
资本支出强度DBVTSPCE
| Q3 25 | 4.2% | — | ||
| Q2 25 | 2.2% | — | ||
| Q2 24 | 63.0% | 815.5% | ||
| Q1 24 | 94.9% | 658.5% | ||
| Q4 23 | 4.0% | 653.9% | ||
| Q3 23 | 2.1% | 771.1% | ||
| Q2 23 | 7.2% | 526.4% | ||
| Q1 23 | 5.1% | — |
现金转化率DBVTSPCE
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | -0.10× | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
